PCN93 Cost-Effectiveness Analysis of DEB-TACE Compared to Lipiodol-TACE As First LINE Treatment for Unresectable HCC Open new browser tab
(2020)
Start website main content
(2020)
(2020)
(2020)
(2020)
(2020)
(2020)
(2020)
(2020)
(2020)
(2020)